CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

  • Matthew J. Frank
  • , John H. Baird
  • , Anne Marijn Kramer
  • , Hrishikesh K. Srinagesh
  • , Shabnum Patel
  • , Annie Kathleen Brown
  • , Jean S. Oak
  • , Sheren F. Younes
  • , Yasodha Natkunam
  • , Mark P. Hamilton
  • , Yi Jiun Su
  • , Neha Agarwal
  • , Harshini Chinnasamy
  • , Emily Egeler
  • , Sharon Mavroukakis
  • , Steven A. Feldman
  • , Bita Sahaf
  • , Crystal L. Mackall
  • , Lori Muffly
  • , David B. Miklos

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science